Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Arantxa Navarré"'
Autor:
Sara Gil-Perotin, Jéssica Castillo-Villalba, Joan Carreres-Polo, Arantxa Navarré-Gimeno, Javier Mallada-Frechín, Francisco Pérez-Miralles, Francisco Gascón, Carmen Alcalá-Vicente, Laura Cubas-Nuñez, Bonaventura Casanova-Estruch
Publikováno v:
Frontiers in Neurology, Vol 9 (2018)
The clinical diagnosis of patients with autoantibodies directed to conformational myelin oligodendrocyte glycoprotein MOG-IgG, can be challenging because of atypical clinical presentation. MOG-IgG seropositivity has been reported in several demyelina
Externí odkaz:
https://doaj.org/article/c6afc20e866a484690af1e431b81a5ff
Autor:
Francisco Pérez-Miralles, Arantxa Navarré, Francisco Gascón, Bonaventura Casanova, Carmen Alcalá, Sara Gil-Perotin, Francisco Coret, Isabel Bosca
Publikováno v:
JOURNAL OF NEUROLOGY
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
Rituximab is considered as a potential therapeutic option in relapsing-remitting (RRMS) and progressive forms (PMS) of multiple sclerosis (MS). To investigate the effectiveness and safety of rituximab in MS. Observational study of effectiveness (clin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d70c97ed69b3ccc5a9ac727aa54c1159
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2654
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=2654
Autor:
Miguel A. Sanz, Francisco Coret, Jaime Sanz, Sara Gil-Perotin, Javier Mallada, Bonaventura Casanova, Arantxa Navarré, Carlos Solano, Juan Carlos Hernández-Boluda, Angeles Cervelló, Isabel Bosca, Isidro Jarque, María Carcelén-Gadea, Francisco Gascón, Carmen Alcalá, Francisco Pérez-Miralles, Javier de la Rubia
Publikováno v:
NEUROLOGICAL SCIENCES
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Neurological Sciences
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname
r-FISABIO. Repositorio Institucional de Producción Científica
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
Neurological Sciences
The main objective of our work is to describe the long-term results of myeloablative autologous hematopoietic stem cell transplant (AHSCT) in multiple sclerosis patients. Patients that failed to conventional therapies for multiple sclerosis (MS) unde
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4dca55bc4abd2c72d572a2ce0f6c7f9
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4892
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=4892
Autor:
Sara Gil-Perotin, Ana Bernad, Carmen Alcalá, Francisco Pérez-Miralles, Francisco Coret, Isabel Bosca, Francisco Gascón, Bonaventura Casanova, Matilde Escutia, Arantxa Navarré
Publikováno v:
Multiple Sclerosis Journal-Experimental, Translational and Clinical
Background Disease-modifying therapies are thought to reduce the conversion rate to secondary progressive multiple sclerosis. Objective To explore the rate, chronology, and contributing factors of conversion to the progressive phase in treated relaps
Autor:
Bonaventura Casanova, MJ Magraner, Isabel Bosca, Matilde Escutia, María Simó, Laura Navarro, Ana Bernad, Arantxa Navarré, Francisco Coret
Publikováno v:
Journal of neurology. 258(10)
In this study, the tolerability and safety of treatment with pulsed steroids and glatiramer acetate and the occurrence of clinical and radiological activity after natalizumab (NTZ) cessation in multiple sclerosis (MS) patients were assessed. MS patie
Autor:
JL León, Francisco Coret, Bonaventura Casanova, Arantxa Navarré, MJ Magraner, L Landete, Isabel Bosca
Publikováno v:
Multiple sclerosis (Houndmills, Basingstoke, England). 16(8)
Objective: To study the long-term outcome and persistence of two patterns of cervical spinal cord abnormality in early relapsing—remitting multiple sclerosis (RRMS). Methods: RRMS patients with a spinal cord MRI performed during the first 3 years o
Publikováno v:
Neurological Sciences. Jul2017, Vol. 38 Issue 7, p1143-1146. 4p.
Autor:
Gil-Perotin, Sara, Castillo-Villalba, Jéssica, Carreres-Polo, Joan, Navarré-Gimeno, Arantxa, Mallada-Frechín, Javier, Pérez-Miralles, Francisco, Gascón, Francisco, Alcalá-Vicente, Carmen, Cubas-Nuñez, Laura, Casanova-Estruch, Bonaventura
Publikováno v:
Frontiers in Neurology; 5/15/2018, p1-5, 5p
Autor:
Coret, Francisco, Pérez-Miralles, Francisco C, Gascón, Francisco, Alcalá, Carmen, Navarré, Arantxa, Bernad, Ana, Boscá, Isabel, Escutia, Matilde, Gil-Perotin, Sara, Casanova, Bonaventura
Supplemental material 2 for Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies by Francisco Coret, Francisco C Pérez-Miralles, Francisco Gascón, Carmen Alcalá, Arantxa Navarré, An
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::112418c86d89b4c3d5f45c14a38082a4
Autor:
Coret, Francisco, Pérez-Miralles, Francisco C, Gascón, Francisco, Alcalá, Carmen, Navarré, Arantxa, Bernad, Ana, Boscá, Isabel, Escutia, Matilde, Gil-Perotin, Sara, Casanova, Bonaventura
Supplemental material 3 for Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies by Francisco Coret, Francisco C Pérez-Miralles, Francisco Gascón, Carmen Alcalá, Arantxa Navarré, An
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c7799083325022468dec588c3eaea3f